About Us
Finding Inspiration in Every Turn

RECARDIO has an experienced management team with longtime and significant experience and reputation in drug development, cardiology, the biotech industry and is complemented by exclusive boards.

Boards
Corporate Board
​
ROMAN SCHENK, MD (Chairman)
Dr. Roman Schenk is chairman of the board, founder and former CEO of RECARDIO Inc.
He is board member of various health care companies and organizations. Before starting his entrepreneurial career, he held European executive management positions in research, marketing and business development in the pharmaceutical industry.
​
​
Scientific Advisory Board
​​
A global Scientific Advisory Board is supporting RECARDIO’s strategy and decisions regarding the scientific and clinical development of the pivotal phase 3 study:
ANDREW COATS, PhD, MD (Chairman)
President of the Heart Failure Association, University of Warwick and Monash, United Kingdom/Australia
​
DEEPAK BHATT, PhD, MD
Executive Director of Interventional Cardiovascular Programs, Professor of Medicine, Harvard Medical School, Boston, USA
​
TIM FRIEDE, PhD
Department of Medical Statistics, University Medical Center, Göttingen, Germany
CAROLYN LAM, PhD, MD
Director of Women’s Heart Health of the National Heart Centre Singapore Professor of Duke-NUS Cardiovascular Academic Clinical Program, Singapore
DIRK VON LEWINSKI, PhD, MD
Assoc. Prof. in Internal Medicine at the Medical University of Graz, Department of Cardiology; Head of Research unit Myocardial Energetics and Metabolism
RICHARD A. SCHATZ, MD
Interventional Cardiology, Research Director Scripps Clinic, Director of Gene and Stem Cell Research, Professor of Medicine, La Jolla, USA
JOHN TEERLINK, MD
Professor of Medicine, University of California, San Francisco (UCSF)
Director, Heart Failure Program, VA Medical Center, San Francisco, USA
​​​
​
Management
​
STEPHAN HENAUER, MD
Chief Medical Officer
​
​MANFRED PAPASPYROU, PhD
Chief Manufacturing Officer
Antonia Klopfer
Director Finance
​​
​